Maryland Senate and House / 2026 Regular Session
HB0417: Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
In the Senate - Special Order until next session (Senator Love) Adopted
Establishing medetomidine and xylazine as Schedule III controlled dangerous substances under the Maryland Controlled Dangerous Substances Act
Official bill page · Source: Maryland General Assembly
Legislative actions
No action history has been imported for this bill. This does not mean the bill had no actions.
Raw source record
{
"Title": "Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine",
"Status": "In the Senate - Special Order until next session (Senator Love) Adopted ",
"BillType": "Regular",
"Sponsors": [
{
"Name": "Delegate Pippy"
},
{
"Name": "Delegate Kerr"
},
{
"Name": "Delegate Alston"
},
{
"Name": "Delegate Bagnall"
},
{
"Name": "Delegate Cullison"
},
{
"Name": "Delegate Guzzone"
},
{
"Name": "Delegate Hill"
},
{
"Name": "Delegate Hutchinson"
},
{
"Name": "Delegate Johnson, S."
},
{
"Name": "Delegate Kaufman"
},
{
"Name": "Delegate Kipke"
},
{
"Name": "Delegate Lopez"
},
{
"Name": "Delegate Martinez"
},
{
"Name": "Delegate Morgan, M."
},
{
"Name": "Delegate Reilly"
},
{
"Name": "Delegate Rosenberg"
},
{
"Name": "Delegate Ross"
},
{
"Name": "Delegate Szeliga"
},
{
"Name": "Delegate Taveras"
},
{
"Name": "Delegate White Holland"
},
{
"Name": "Delegate Woorman"
}
],
"Statutes": [
{
"Article": {
"Code": "gcr",
"Title": "Criminal Law"
},
"Sections": [
{
"Section": "5-404"
}
]
}
],
"Synopsis": "Establishing medetomidine and xylazine as Schedule III controlled dangerous substances under the Maryland Controlled Dangerous Substances Act",
"BillNumber": "HB0417",
"BillVersion": "T",
"PassedByMGA": false,
"BroadSubjects": [
{
"Code": "e1",
"Name": "Criminal Law - Substantive Crimes"
}
],
"ChapterNumber": "",
"EmergencyBill": false,
"NarrowSubjects": [
{
"Code": "age",
"Name": "Age -see also- Age of Maj; Children; Elderly; Inf&Tod.; etc"
},
{
"Code": "classid",
"Name": "Classifications and Designations"
},
{
"Code": "comptroller",
"Name": "Comptroller"
},
{
"Code": "consump",
"Name": "Consumer Protection"
},
{
"Code": "controds",
"Name": "Controlled Dangerous Substances -see also- Drugs; Opioids"
},
{
"Code": "drugs",
"Name": "Drugs -see also- Cannabis; ControlDangSubst; Pharm; etc."
},
{
"Code": "health",
"Name": "Health -see also- COVID19; EnvHlth; MedCon; etc."
},
{
"Code": "healthd",
"Name": "Health, Department of"
},
{
"Code": "identificatio",
"Name": "Identification -see also- Biometrics; Fingerprinting; DrLics"
},
{
"Code": "penalts",
"Name": "Penalties and Sentences -see also- Death Penalty"
},
{
"Code": "records",
"Name": "Records -see also- Land Records; Vital Records"
},
{
"Code": "retails",
"Name": "Retail Sales"
},
{
"Code": "revenut",
"Name": "Revenue and Taxes -see also- (specific tax)"
},
{
"Code": "rulesr",
"Name": "Rules and Regulations"
},
{
"Code": "scientr",
"Name": "Scientific Research -see also- ChemTst; MedRsrch; Studies"
},
{
"Code": "substaa",
"Name": "Substance Abuse"
},
{
"Code": "veterinarians",
"Name": "Veterinarians"
},
{
"Code": "wholesd",
"Name": "Wholesale Distribution"
}
],
"SponsorPrimary": "Delegate Pippy",
"YearAndSession": "2026 Regular Session",
"StatusCurrentAsOf": "2026-11-13T11:57:19.330",
"CrossfileBillNumber": "SB0435",
"CommitteePrimaryOrigin": "Health",
"ConstitutionalAmendment": false,
"ReportDateHouseOfOrigin": "2026-03-03",
"ReportDateOppositeHouse": "2026-04-13",
"CommitteePrimaryOpposite": "Finance",
"CommitteeSecondaryOrigin": "",
"ReportActionHouseOfOrigin": "Favorable with Amendments",
"ReportActionOppositeHouse": "Favorable",
"CommitteeSecondaryOpposite": "",
"InteractionBetweenChambers": "",
"FirstReadingDateHouseOfOrigin": "2026-01-22",
"FirstReadingDateOppositeHouse": "2026-02-22",
"ThirdReadingDateHouseOfOrigin": "2026-02-23",
"ThirdReadingDateOppositeHouse": null,
"SecondReadingDateHouseOfOrigin": "2026-02-22",
"SecondReadingDateOppositeHouse": null,
"ThirdReadingActionHouseOfOrigin": "Passed",
"ThirdReadingActionOppositeHouse": "",
"SecondReadingActionHouseOfOrigin": "Passed with Amendments",
"SecondReadingActionOppositeHouse": "",
"HearingDateTimePrimaryHouseOfOrigin": "2026-02-10T14:30:00",
"HearingDateTimePrimaryOppositeHouse": null,
"HearingDateTimeSecondaryHouseOfOrigin": null,
"HearingDateTimeSecondaryOppositeHouse": null
}